HYANGSOOK PATEL: Open Payments
NPI 1174155089 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 15 payments from 6 companies in 2025. Trend: 2023 $1,259 · 2024 $1,208 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $75 |
| Lundbeck LLC | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ABBVIE INC. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
Products named: REXULTI, FANAPT, VRAYLAR, CAPLYTA, COBENFY.
Industry payments across AZ — which companies pay providers there.
